ACtive Catheterization for EndovaScular TreatmentS (ACCESS)

  • End date
    Jun 28, 2023
  • participants needed
  • sponsor
    Basecamp Vascular
Updated on 4 October 2022


The objective of this clinical investigation is to evaluate the safety and technical success of the Basecamp Vascular controllable directional GECKO guidewire when used to facilitate endovascular access to the targeted vessel in order to treat the vascular lesion.


The Basecamp Vascular trial is a prospective monocenter, non-randomized, open clinical investigation of their controllable directional GECKO guidewire which has not yet received the CE mark. The GECKO active guidewire is a sterile, single-use device to be used by interventional neuroradiologists (INR) to position a distal access catheter (DAC). The device is a system composed of a deflector (the guide) and a handle. The handle contains the battery and integrated electronics. The device can be activated using buttons on the handle. When the user presses a button, a current is transmitted along the guide to its end: this allows the guide to bend (two possible curves). The end of the device can then take an "S" shape. In INR, the placement of a DAC (at the cervical level) is the first step of an endovascular intervention (Primary Access). This is followed by the treatment phase of the vascular pathology with other medical devices (example: embolization, angioplasty). The GECKO active guide is a system that facilitates endovascular navigation and allows the positioning of the DAC via vascular access (femoral or radial artery). The GECKO device is intended to introduce devices used for treatment, at a desired anatomical location (cervical carotid artery, for example) in the central circulatory system. The GECKO guidewire itself is not meant to perform a treatment but is used to set the primary access that will allow performance of the treatments.

Condition Unruptured Intracranial Aneurysm, Arteriovenous Cerebral Malformations, Carotid Stenosis
Treatment GECKO Active Guidewire
Clinical Study IdentifierNCT05355259
SponsorBasecamp Vascular
Last Modified on4 October 2022


Yes No Not Sure

Inclusion Criteria

Male or female ≥18 years old
An unruptured intracranial aneurysm, a brain arteriovenous malformation (bAVM) or dural arteriovenous fistula (DAVF) or an internal carotid artery (ICA) stenosis
Subject can receive, if necessary, anti-coagulation and anti-platelet therapy according to the standard used in each study center
Subject is eligible to undergo a procedure with the use of contrast media
Subject is willing to comply with protocol requirements and return to the treatment center for all required clinical evaluations and follow-up
Subject has given written informed consent
Life expectancy >12 months

Exclusion Criteria

Subject is unconscious and unable to directly provide his/her written informed consent
Subject with a type 3 aortic arch will be excluded from the study
Subject is or has been treated with radiation therapy to the neck or chest
Subject has a life-threatening allergy to contrast media (unless treatment for allergy can be tolerated)
Subject has a known cardiac disorder, likely to be associated with cardio-embolic symptoms such as atrial fibrillation (AFib)
Subject has any condition, which in the opinion of the treating physician, would place the subject at a high risk of embolic stroke
Subject is unable to complete the required follow-up
Subject is pregnant or breastfeeding. (Females of childbearing potential who are less than 45 years old must have a pregnancy test and provide written proof that they are not pregnant prior to inclusion.)
Subject has participated in a clinical study within the last 30 days
Subject with cardiac pacemaker or defibrillator
Persons under guardianship or curatorship
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note